Hält derzeit Positionen bei PTC Therapeutics Inc, Xenon Pharmaceuticals Inc and Global Blood Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | PTC Therapeutics Inc | 13. Juni 2016 - |
Independent Director | Xenon Pharmaceuticals Inc | 27. September 2016 - |
Independent Director | Global Blood Therapeutics Inc | 19. Dezember 2018 - |
Director | Endocyte Inc | None - |
Independent Director | Medivation Inc | 1. Dezember 2014 - 28. September 2016 |
Interim Chief Commercial Officer, Director | Medivation Inc | 10. Juli 2014 - 1. Dezember 2014 |
Independent Director | Medivation Inc | 1. April 2013 - 10. Juli 2014 |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2023-08-24 | 2023-08-24 |
Xenon Pharmaceuticals Inc
(XENE)
|
V Verkauf |
25.000
-50.0%
38,70967.500 USD |
25.000 -50.0% | 38,70 | 967.500 USD | |
2023-05-11 | 2023-05-09 |
ACELYRIN Inc
(SLRN)
|
K Kauf |
15.000
+inf%
18,00270.000 USD |
15.000 +inf% | 18,00 | 270.000 USD | |
2022-06-22 | 2022-06-21 | GV Geplanter Verkauf |
1.908
-26.2%
27,2451.983 USD |
1.908 -26.2% | 27,24 | 51.983 USD | ||
2022-06-10 | 2022-06-09 |
PTC Therapeutics Inc
(PTCT)
|
V Verkauf |
738
-2.5%
27,2020.074 USD |
738 -2.5% | 27,20 | 20.074 USD | |
2022-05-18 | 2022-05-16 |
Adverum Biotechnologies Inc
(ADVM)
|
K Kauf |
30.000
+150.0%
0,8525.578 USD |
30.000 +150.0% | 0,85 | 25.578 USD | |
2022-01-11 | 2022-01-07 |
PTC Therapeutics Inc
(PTCT)
|
V Verkauf |
510
-1.9%
38,5319.648 USD |
510 -1.9% | 38,53 | 19.648 USD | |
2021-06-21 | 2021-06-18 | GV Geplanter Verkauf |
1.609
-30.4%
36,5458.793 USD |
1.609 -30.4% | 36,54 | 58.793 USD | ||
2021-06-11 | 2021-06-09 |
PTC Therapeutics Inc
(PTCT)
|
V Verkauf |
365
-1.3%
41,8915.288 USD |
365 -1.3% | 41,89 | 15.288 USD | |
2021-04-01 | 2021-03-31 |
Adverum Biotechnologies Inc
(ADVM)
|
K Kauf |
20.000
+inf%
10,02200.338 USD |
20.000 +inf% | 10,02 | 200.338 USD | |
2021-02-02 | 2021-02-01 |
PTC Therapeutics Inc
(PTCT)
|
V Verkauf |
506
-1.8%
56,9628.820 USD |
506 -1.8% | 56,96 | 28.820 USD | |
2020-06-19 | 2020-06-19 | GV Geplanter Verkauf |
881
-28.1%
64,4256.750 USD |
881 -28.1% | 64,42 | 56.750 USD | ||
2020-06-19 | 2020-06-19 | GV Geplanter Verkauf |
1.663
-34.6%
63,69105.913 USD |
1.663 -34.6% | 63,69 | 105.913 USD | ||
2020-06-12 | 2020-06-11 |
PTC Therapeutics Inc
(PTCT)
|
V Verkauf |
364
-1.4%
48,3617.603 USD |
364 -1.4% | 48,36 | 17.603 USD |